Alton Gregg H — SEC Form 4 filings
SEC reporting owner CIK 1334682. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-02 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NOVAVAX INC (NVAX) | Director | 5 | — | — | 16 |
| CORCEPT THERAPEUTICS INC (CORT) | Director | 3 | — | — | 3 |
| RENOVARO INC. (RENB) | Director | 2 | — | — | 2 |
Form 4 filings — Alton Gregg H
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 18,880 · Grant/award (A): 21,270 (derivative) @ $0 · Grant/award (A): 14,180 (derivative) @ $0 · Option exercise (M): 18,880 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | NOVAVAX INC (NVAX) | Grant/award (A): 28,326 (derivative) @ $6.42 · Grant/award (A): 18,884 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 10,420 @ $0 · Option exercise (M): 10,420 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-02-05 | 4 | NOVAVAX INC (NVAX) | Grant/award (A): 3,420 @ $4.90 · Grant/award (A): 1,202 @ $13.93 · Grant/award (A): 1,311 @ $12.77 · Grant/award (A): 1,982 @ $8.61 | EDGAR |
| 2024-06-27 | 4 | RENOVARO INC. (RENB) | Grant/award (A): 48,137 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | NOVAVAX INC (NVAX) | Option exercise (M): 6,670 @ $0 · Option exercise (M): 6,670 (derivative) @ $0 · Grant/award (A): 15,630 (derivative) @ $15.86 · Grant/award (A): 10,420 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | RENOVARO BIOSCIENCES INC. (RENB) | Grant/award (A): 23,810 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1334682 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →